Articles

FDA granted priority review for Pfizer’s Marstacimab, a weekly subcutaneous anti-TFPI to treat pediatric and inhibitor hemophilia.

FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B

Videos

This week, we look at a cross-industry shift toward integrated automation, domestic resilience, and a critical focus on the human talent pipeline.

PharmTech Weekly Roundup - February 6, 2026

Marcio Temtem, vice president, Strategic Business Management, Hovione, addresses molecule complexity, speed, and regionalization via integrated manufacturing.

Hovione’s Strategy for Complexity, Speed, and Regional Supply Chains

Oncologist Dr. Maria de Miguel, MD, PhD, MBA, Director, Clinical Research for START Rioja, spoke with PharmTech about the importance of STEM education in early phase drug development.

Women in STEM: Early Phase Drug Development

Feliza Mirasol is the science editor for 

Strategic outsourcing utilizes external expertise to accelerate the biopharma pipeline, integrating specialized workflows that drive efficiency from discovery through early clinical trials.

Drug Digest:  Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up

, specializes in business development, new product planning, and early brand strategy. He helps companies lay the foundation for successful launches through data-backed strategies spanning indication assessment to portfolio strategy. With a strong background in pricing and market access, Nathan integrates both commercial and access insights into early asset development to maximize market opportunity.

In part two of this four-part series regarding rare diseases, the author examines how economic and structural forces are driving an access gap.

Rare Disease Treatments: Navigating the Economics of Global Innovation

ACG’s Shirwal site is the first pharmaceutical packaging site in the WEF Lighthouse Network, using digital tools to cut defects and boost sustainability.

WEF Welcomes ACG Shirwal as First Pharma Packaging Site in Global Lighthouse Network

PharmTech spoke with Elisabeth Gardiner, chief scientific officer at Tevard Biosciences, about how hands-on, early exposure to STEM fields can demystify complex concepts.

Women in STEM: Cultivating Scientific Confidence

Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.

Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies

FDA has granted priority review to AstraZeneca's Datroway for the first-line treatment of metastatic TNBC treatment.

News